Synonyms- |
Introduction- |
Target |
Mechanism HBcrAg inhibitors [+2] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Mechanism MPXV A29L inhibitors [+3] |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism Viral antigens modulators |
Active Org.- |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date30 May 2023 |
Sponsor / Collaborator |
Start Date26 Jan 2021 |
Sponsor / Collaborator |
Start Date22 Jan 2019 |
Sponsor / Collaborator |